Search results
Battling CRMO: Inspiring Metro Detroit figure skater overcomes rare bone disease
ClickOnDetroit· 23 hours agoA Metro Detroit figure skater is battling a condition that attacks her bones, which would seem like...
Takeda tackles $900m restructuring plan after generics hurt annual profits
Pharmaceutical Technology via Yahoo Finance· 6 days agoThese programs involve therapies to treat rare blood disorders, psoriasis and neurological...
Japan's Takeda Pharma to restructure after annual profit slump
Reuters· 6 days ago, opens new tab announced a restructuring on Thursday after annual profit slid by more than half...
Biodexa Pharmaceuticals (LON:MTPH) Share Price Passes Above 50 Day Moving Average of $18.00
ETF DAILY NEWS· 2 days agoBiodexa Pharmaceuticals Plc (LON:MTPH – Get Free Report) shares passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 18 ($0.23) and ...
Kids With Skin Diseases Face Stigma, Reduced Quality of Life
Medscape· 3 days agoMost children with chronic skin diseases — such as acne, alopecia, eczema, psoriasis, and vitiligo —...
Q1 2024 Nektar Therapeutics Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 days agoAdditionally, REZPEG was well-tolerated and treatment with REZPEG did not induce anti-drug antibodies in patients, which has been reported with some examples in the IL-2 mutein ...
Amgen Inc. (AMGN) To Go Ex-Dividend on May 16th
ETF DAILY NEWS· 2 days agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) announced a quarterly dividend on Wednesday, March 6th, RTT News reports. This represents a $9.00 annualized dividend and a dividend yield of 2.92% ...
Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoNektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript May 9, 2024 Nektar Therapeutics...
Against Sunscreen Absolutism
The Atlantic· 5 days agoThe country’s predominantly white population has by far the world’s highest rate of skin cancer, and for years the public-health establishment has warned...
vTv Therapeutics (NASDAQ:VTVT) Lowered to Sell at StockNews.com
ETF DAILY NEWS· 2 days agoStockNews.com cut shares of vTv Therapeutics (NASDAQ:VTVT – Free Report) from a hold rating to a sell rating in a research report report published on Monday. vTv Therapeutics Trading Down 0.3 ...
